Literature DB >> 28041586

Thyroid nodules: Α guide to assessment, treatment and follow-up.

Stavroula A Paschou1, Andromachi Vryonidou2, Dimitrios G Goulis3.   

Abstract

Thyroid nodules constitute by far the most common disorder of the endocrine system. Epidemiological studies have indicated that approximately 5% of women and 1% of men resident in iodine-sufficient areas have palpable thyroid nodules. However, by the age of 60 years about 50% of the general population is estimated to have at least one thyroid nodule. Indeed, the reported prevalence of a "thyroid incidentaloma" is up to 70% when neck/carotid artery ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) is performed for other indications. Of those with a nodule, 7-15% will have a thyroid carcinoma. The objective of this article is to present updated information on the definition, prevalence, imaging and functional features of thyroid nodules and to provide guidance on the optimal assessment, treatment and follow-up strategy. The endocrinologist dealing with a patient with a thyroid nodule has to consider two main clinical issues: (i) the possibility of thyroid hormonal excess (hyperthyroidism) and (ii) the risk of malignancy. The former is determined by the assessment of the serum concentrations of thyroid stimulating hormone (TSH), as well as of peripheral thyroid hormones and a thyroid radionuclide scan, if necessary; the latter is achieved by the use of thyroid ultrasonography, as well as fine needle aspiration cytology (FNAC) and serum calcitonin measurement, if necessary. These assessments will guide management, which can vary from simple follow-up to surgical resection. The indications for surgical management, simple follow-up, conservative therapy or treatment with radioactive iodine are discussed.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Fine needle aspiration; Hyperthyroidism; Nodule; Thyroid

Mesh:

Substances:

Year:  2016        PMID: 28041586     DOI: 10.1016/j.maturitas.2016.11.002

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  13 in total

1.  Identification of circulating biomarkers for differentiating patients with papillary thyroid cancers from benign thyroid tumors.

Authors:  S-C Wu; S-Y Chi; C-S Rau; P-J Kuo; L-H Huang; Y-C Wu; C-J Wu; H-P Lin; C-H Hsieh
Journal:  J Endocrinol Invest       Date:  2021-03-01       Impact factor: 4.256

2.  Elevated serum growth differentiation factor 15 levels are associated with thyroid nodules in type 2 diabetes aged over 60 years.

Authors:  Hongmei Zhang; Weiwei Zhang; Xiaofang Tu; Yixin Niu; Xiaoyong Li; Li Qin; Zhen Yang; Qing Su
Journal:  Oncotarget       Date:  2017-06-20

3.  Improvement of diagnostic efficiency in distinguishing the benign and malignant thyroid nodules via conventional ultrasound combined with ultrasound contrast and elastography.

Authors:  Mei-Juan Liu; Yan-Ming Men; Yong-Lin Zhang; Yu-Xi Zhang; Hao Liu
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

Review 4.  Controversy regarding when clinically suspicious thyroid nodules should be subjected to surgery: Review of current guidelines.

Authors:  Brandon Spencer Jackson
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

5.  Occult papillary thyroid cancer presenting as cystic metastasis of the lateral neck: A case report.

Authors:  Karl Schwaiger; Fabian Koeninger; Julia Wimbauer; Klemens Heinrich; Alexandra Gala-Kokalj; Gottfried Wechselberger
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  The Role of Metabolic Volumetric Parameters in Predicting Malignancy in Incidental Thyroid Nodules Detected in 18F-FDG PET/CT Scans

Authors:  Mehmet Erdoğan; Hakan Korkmaz; Bora Torus; Mustafa Avcı; Şerife Mehtap Boylubay; Metin Çiriş; Mustafa Yıldız; Sevim Süreyya Şengül
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03

7.  The association between BMI, smoking, drinking and thyroid disease: a cross-sectional study in Wuhan, China.

Authors:  Xiao Chen; Juan-Juan Wang; Li Yu; Han-Yu Wang; Hui Sun
Journal:  BMC Endocr Disord       Date:  2021-09-13       Impact factor: 2.763

8.  A Single-Center Retrospective Study of the Impact of Thyroid Cancer on the Malignant Risk of Contralateral TI-RADS 3 and 4 Nodules.

Authors:  Huan Liu; Jun Jin; Qiao Chen; Zhongmin Li
Journal:  Int J Endocrinol       Date:  2021-10-07       Impact factor: 3.257

9.  TI-RADS Diagnostic Performance: Which Algorithm is Superior and How Elastography and 4D Vascularity Improve the Malignancy Risk Assessment.

Authors:  Andreea Borlea; Florin Borcan; Ioan Sporea; Cristina Adriana Dehelean; Romeo Negrea; Laura Cotoi; Dana Stoian
Journal:  Diagnostics (Basel)       Date:  2020-03-26

10.  Development and validation of a survival model for thyroid carcinoma based on autophagy-associated genes.

Authors:  Baoai Han; Xiuping Yang; Davood K Hosseini; Pan Luo; Mengzhi Liu; Xiaoxiang Xu; Ya Zhang; Hongguo Su; Tao Zhou; Haiying Sun; Xiong Chen
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.